Telmacal 5 mg+40 mg (Tablet)
Unit Price: ৳ 12.50 (3 x 10: ৳ 375.00)
Strip Price: ৳ 125.00
Medicine Details
Category | Details |
---|---|
Generic | Amlodipine besilate telmisartan |
Company | Beximco pharmaceuticals ltd |
Also available as |
Indications
- Treatment of hypertension
- Treatment with other antihypertensive agents
- Initial therapy for multiple drugs
Pharmacology
- Fixed dose combination of Telmisartan and Amiodipine
- Telmisartan: Angiotensin receptor blocker (ARB)
- Telmisartan: Selectively blocks the AT1 receptor
- Telmisartan: Blocks vasoconstrictor and aldosterone-secreting effects
- Telmisartan: Dilates blood vessels and reduces blood pressure
- Amiodipine: Dihydropyridine calcium-channel blocker (CCB)
- Amiodipine: Inhibits transmembrane influx of calcium ion into vascular smooth muscle and cardiac muscle
- Amiodipine: Acts directly on vascular smooth muscle to reduce peripheral vascular resistance and blood pressure
Dosage & Administration
- Usual starting dose: 40/5 mg once daily
- Patients requiring larger blood pressure reductions may be started with 80/5 mg once daily
- Maximum recommended dose: 80/10 mg once daily
- Not recommended for patients 575 years old or with hepatic impairment
Interaction
- Co-administration of telmisartan did not result in clinically significant interaction with various drugs
- Amiodipine has been safely administered with several other drug classes
Contraindications
- Known hypersensitivity to the product or its components
- Pregnancy & lactation
- Biliary obstructive disorders, severe hepatic impairment, hypotension, cardiogenic shock, left ventricle outflow tract obstruction
Side Effects
- Dizziness
- Peripheral edema
- Migraine
- Headache
- Bradycardia
- Palpitations
- Hypotension
- Cough
- Abdominal pain
- Diarrhea
- Nausea
- Pruritus
- Myalgia
- Erectile dysfunction
- Chest pain
- Fatigue
Pregnancy & Lactation
- Pregnancy Categories C (first trimester) and D (second and third trimesters)
- No known excretion in human milk, discontinue nursing or drug use after considering importance to the mother
Precautions & Warnings
- Avoid fetal or neonatal exposure
- Correct any volume or salt depletion before initiating therapy
- Monitor for hypotension
- Slow titration in patients with hepatic or severe renal impairment
- Monitor for worsening heart failure
- Avoid concomitant use of an ACE inhibitor and angiotensin receptor blocker
Use in Special Populations
- Safety and effectiveness in pediatric patients not established
- Initial therapy not recommended in patients 75 years old or with hepatic impairment
Overdose Effects
- Telmisartan overdose: Manifestations may include hypotension, dizziness, and tachycardia
- Amiodipine overdose: Manifestations may include excessive peripheral vasodilation with marked hypotension and possibly reflex tachycardia
- Supportive treatment should be instituted for symptomatic hypotension
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Protect from light and high humidity
- Keep out of the reach of children